Showing results (251-260 of 908) with videos related to
Sort By:
Pageof 91
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 30, 2017
Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database InitiativeStefano Coiro, Nicolas Girerd, Patrick Rossignol, et al.Biometrics|August 25, 2015
On the restricted mean survival time curve in survival analysisLihui Zhao, Brian Claggett, Lu Tian, et al.European Journal of Heart Failure|May 8, 2012
Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney diseaseBertram Pitt, Gerasimos Filippatos, Mihai Gheorghiade, et al.Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|January 21, 2006
Risk assessment in patients with depressed left ventricular function after myocardial infarction using the myocardial performance index--Survival and Ventricular Enlargement (SAVE) experienceNagesh S Anavekar, Atique Mirza, Hicham Skali, et al.The American Journal of Cardiology|April 11, 2018
Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative)Zied Frikha, João Pedro Ferreira, Erwan Bozec, et al.Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.JAMA Cardiology|December 1, 2021
Practical Recommendations on Quantifying and Interpreting Treatment Effects in the Presence of Terminal Competing Risks: A ReviewZachary R McCaw, Brian Lee Claggett, Lu Tian, et al.European Journal of Heart Failure|August 2, 2005
Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysisJawdat Abdulla, Janice Pogue, Steen Z Abildstrøm, et al.Transplantation|September 23, 2025
Safety and Tolerability of Sotagliflozin Among Kidney Transplant RecipientsMartina M McGrath, Finnian R Mc Causland, Brian L Claggett, et al.European Journal of Heart Failure|November 11, 2003
Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)Jay N Cohn, Marc A Pfeffer, Jean Rouleau, et al.Pageof 91